|
|
||||||||
RESEARCH AND PRACTICE |
Anne N. Thorndike and Nancy A. Rigotti are with the General Medicine Division, Tobacco Research and Treatment Center, Medical Services, Massachusetts General Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass. Lois Biener is with the Center for Survey Research, University of Massachusetts, Boston. Nancy A. Rigotti is also with the Institute for Health Policy, Massachusetts General Hospital/Partners HealthCare System, Inc, Boston, Mass.
Correspondence: Requests for reprints should be sent to Anne N. Thorndike, MD, MPH, Massachusetts General Hospital, General Medicine Unit, S50-9, Boston, MA 02114 (e-mail: athorndike{at}partners.org).
Objectives. This study examined whether the change in nicotine replacement therapy sales from prescription to over the counter (OTC) status affected smoking cessation.
Methods. We used the 19931999 Massachusetts Tobacco Surveys to compare data from adult current smokers and recent quitters before and after the OTC switch.
Results. No significant change over time occurred in the proportion of smokers who used nicotine replacement therapy at a quit attempt in the past year (20.1% pre-OTC vs 21.4% post-OTC), made a quit attempt in the past year (48.1% vs 45.2%), or quit smoking in the past year (8.1% vs 11.1%). Fewer non-Whites used nicotine replacement therapy after the switch (20.7% pre-OTC vs 3.2% post-OTC, P = .002), but the proportion of Whites using nicotine replacement therapy did not change significantly (20.6% vs 24.0%).
Conclusions. We observed no increase in Massachusetts smokers' rates of using nicotine replacement therapy, making a quit attempt, or stopping smoking after nicotine replacement therapy became available for OTC sale. There appear to be other barriers to the use of nicotine replacement therapy besides visiting a physician, especially among minority smokers. (Am J Public Health. 2002;92:437442)
This article has been cited by other articles:
![]() |
M. A. Wakefield, S. Durkin, M. J. Spittal, M. Siahpush, M. Scollo, J. A. Simpson, S. Chapman, V. White, and D. Hill Impact of Tobacco Control Policies and Mass Media Campaigns on Monthly Adult Smoking Prevalence Am J Public Health, August 1, 2008; 98(8): 1443 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Messer, D. R. Trinidad, W. K. Al-Delaimy, and J. P. Pierce Smoking Cessation Rates in the United States: A Comparison of Young Adult and Older Smokers Am J Public Health, February 1, 2008; 98(2): 317 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Levy, A. N Thorndike, L. Biener, and N. A Rigotti Use of nicotine replacement therapy to reduce or delay smoking but not to quit: prevalence and association with subsequent cessation efforts Tob. Control, December 1, 2007; 16(6): 384 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. West and X. Zhou Is nicotine replacement therapy for smoking cessation effective in the "real world"? Findings from a prospective multinational cohort study Thorax, November 1, 2007; 62(11): 998 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
W K Al-Delaimy, E A Gilpin, and J P Pierce When California smokers use nicotine replacement therapy, most are trying to quit smoking Tob. Control, October 1, 2005; 14(5): 359 - 360. [Full Text] [PDF] |
||||
![]() |
M. B. Reed, C. M. Anderson, J. W. Vaughn, and D. M. Burns The Effect of Over-the-Counter Sales of the Nicotine Patch and Nicotine Gum on Smoking Cessation in California Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2131 - 2136. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Raymond, P.-L. Chen, and S. M. Dalebout "Actual Use" Study of Emergency Contraceptive Pills Provided in a Simulated Over-the-Counter Manner Obstet. Gynecol., July 1, 2003; 102(1): 17 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Franzon, G. Gustavsson, B. H. Korberly, D. O. Antonuccio, J. M. Cadore, L. F. Stead, R. M. Davis, M. C. Fiore, D. K. Hatsukami, M. Raw, et al. Effectiveness of Over-the-Counter Nicotine Replacement Therapy JAMA, December 25, 2002; 288(24): 3108 - 3110. [Full Text] [PDF] |
||||
![]() |
C Miller, S Kriven, D Rowley, and L Abram Be wary of subsidising nicotine replacement therapy Tob. Control, December 1, 2002; 11(4): 380 - 381. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |